Tiziana von Bruchhausen PhD
Boehringer Ingelheim Pharma
Principal Global Pharmacovigilance Writer – Boehringer Ingelheim Pharma
Tiziana has been specialising in pharmacovigilance writing since 2008 and has gained extensive hands-on experience with pharmacovigilance documents and health authority assessments. She has developed broad expertise with the implementation of the Good Pharmacovigilance Practice (GVP) guideline related to Risk-Management Plans (RMPs) and Periodic Safety Update Reports (PSURs), and with the evolving concept of safety concerns. In her current position at Boehringer Ingelheim, she is responsible for the coordination and preparation of lifecycle pharmacovigilance documents with a focus on Development Safety Update Reports (DSURs), RMPs, and PSURs; in addition, she is involved in pre- and post-submission activities related to the global strategic planning and health authority assessment reports.
Tiziana provides trainings on pharmacovigilance writing for professional education institutions Europe-wide, including EMWA. She has been a member of EMWA since 2009 and a workshop leader since 2013. She covered various roles at EMWA: Vice President/President in 2017-2019, Committee Member of the Communicating with the Public Special Interest Group (SIG) in 2021-2024, and Chair of the Expert Seminar Series Committee in 2022-2024. Since 2017, she has been chairing the EMWA’s Pharmacovigilance SIG.